NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
1205.10
Change Change %
70.35 6.20%

Updated:27 Mar, 2015, 15:51 PM IST

BSE
1204.15
Change Change %
68.60 6.04%

Updated:27 Mar, 2015, 15:58 PM IST

Period:

Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)

Day's Range

1142.00 1216.80

52 Wk Range

503.40 1279.80
Period:

Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)

Day's Range

1141.001215.00

52 Wk Range

504.50 1279.05

Compare Price performance of vs. Peer Companies

From sector

Compare with Peers on Key Fundamentals and Financials

Color code for Price performance of and Peer companies

  • 5% and above
  • 2% to 5%
  • 0.5% to 2%
  • -0.5% to 0.5%
  • -2% to -0.5%
  • -5% to -2%
  • -5% and below

's Latest Research Report

Brokerage/Analyst Report Date Call Price@Call Target Current Status Report
Citi
-
19-03-2015 Buy 1262.10 1945.00 Open Details
Bank of America Merrill Lynch
-
20-02-2015 Buy 1038.05 1430.00 Open Details
Citi
-
06-02-2015 Buy 1144.00 1945.00 Open Details
Bank of America Merrill Lynch
-
11-08-2014 Buy 753.25 915.00 Target Hit Details
Bank of America Merrill Lynch
-
15-07-2014 Buy 688.30 880.00 Target Hit Details

More from Research Reports »

Aurobindo Pharma's Key Fundamentals

Parameter Values
Market Cap (in ₹ Cr.) 35,186.75
Earning Per Share (EPS TTM) (₹) 55.23
Price To Earnings (P/E) Ratio 21.82
Book Value Per Share (₹) 137.65
Price To Books (P/B) Ratio 8.75
EBIT Margin (%) 24.88
PAT Margin (%) 16.12
ROCE (%) 28.57
PAT Growth (%) 136.31
Total Debt to Equity (D/E) Ratio 0.73

More from Key Fundamentals »

Aurobindo Pharma's Financial Summary

Parameter MAR'14
(₹ Cr.)
MAR'13
(₹ Cr.)
YoY
%Change
Balance Sheet:
Share Capital 29.15 29.12 0.10%
Total Non-Current Liabilities 1,245.86 1,117.50 11.49%
Total Current Liabilities 3,317.28 2,767.96 19.85%
Total Liabilities 8,575.53 6,824.57 25.66%
Total Non-Current Assets 3,494.35 3,193.87 9.41%
Currents Investments 0.03 0.04 -25.00%
Cash and Bank 9.72 114.57 -91.52%
Total Current Assets Excluding Current Investments 5,081.15 3,630.66 39.95%
Total Assets 8,575.53 6,824.57 25.66%
Profit and Loss:
Gross Sales 7,269.53 5,569.50 30.52%
Net Sales 7,110.71 5,425.10 31.07%
PBIDT (Excl OI) 1,919.47 958.06 100.35%
PAT 1,172.09 495.99 136.31%

More from Financial Summary �

Aurobindo Pharma's Shareholding Pattern

's Futures and Options Quotes

Contract
Expiry Date
Type Current price Change Change % Premium / Discount
AUROPHARMA
30-04-2015
FUTSTK
1171.85 22.35 1.94% -33.25
AUROPHARMA
28-05-2015
FUTSTK
1178.80 20.05 1.73% -26.30
AUROPHARMA
25-06-2015
FUTSTK
1185.00 25.55 2.20% -20.10

More from Futures and Options Quotes »

Post your comments about Aurobindo Pharma